Funds holding AVALYN PHARMA INC
ISIN US05348Y1055 · United States
- Fund holders
- 113
- Of which ETFs
- 11 102 other funds
- Value held
- 245.3M $
- Share of capital
- 17.9 % of 44.3M shares on Aug 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| PD Small-Cap Value Index Portfolio PACIFIC SELECT FUND | 274 | 9K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| VANGUARD RUSSELL 3000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 263 | 7.6K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 220 | 6.3K $ | 0.01 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Victory Science & Technology Fund Victory Portfolios III | 200 | 5.8K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 153 | 5K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 92 | 3K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 70 | 2.3K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 46 | 1.5K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 45 | 1.5K $ | 0.04 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 42 | 1.4K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 25 | 823 $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 14 | 403.1 $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 5 | 164.6 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| PGIM Jennison Health Sciences Fund Prudential Sector Funds, Inc. | 0.66 % | as of May 29, 2026 ↗ |
| Hypatia Women CEO ETF Two Roads Shared Trust | 0.49 % | as of Jul 31, 2026 ↗ |
| Fidelity Small Cap Growth Fund Fidelity Securities Fund | 0.40 % | as of Jul 31, 2026 ↗ |
| Fidelity Small Cap Growth K6 Fund Fidelity Securities Fund | 0.39 % | as of Jul 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 0.30 % | as of Jul 31, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 0.21 % | as of Jul 31, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 0.18 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 0.18 % | as of Jun 30, 2026 ↗ |
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 0.16 % | as of Jul 31, 2026 ↗ |
| Fidelity Small Cap Stock Fund Fidelity Concord Street Trust | 0.16 % | as of Jul 31, 2026 ↗ |
Declared shareholders of AVALYN PHARMA INC
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| FMR LLC and 1 other | 13.20 % | 5,835,259 | as of Jun 30, 2026 · SCHEDULE 13G |
| Novo Holdings A/S | 8.80 % | 3,883,289 | as of Jun 30, 2026 · SCHEDULE 13G |
| Norwest Venture Partners XV, LP and 4 others | 5.10 % | 2,268,404 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding AVALYN PHARMA INC". https://titelia.com/en/stocks/avalyn-pharma-inc-US05348Y1055